BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       


March Archive 2005 - have your press release here?

Oxford Biomedica Receives Notice Of Allowance For Us Lentivector® Patent

Peakdale and BioLeap collaborate on drug-like kinase library

ESBATech starts drug discovery collaboration with Novartis

tgAAVCF: Will The Latest Failure Be The Straw That Breaks Investor’s Backs?

Big pharma set to move into HIV/hepatitis co-infection niche

Agilent Technologies Presents Microfluidic Technology for Quality Enhancement of Mitochondrial DNA Sequencing

NIH awards two-year grant to explore the causal relationship between epoetin dose and survival of hemodialysis patients receiving this therapy

Haematologic Technologies, Inc. Has Been Awarded A Phase II SBIR Grant To Research And Manufacture Murine Coagulation Proteins And Related Immunoassays For Knock-Out, Transgenic, And Mouse Model Experiments

Barroso Commission recognises contribution of biotech crops to European competitiveness

Borean Pharma raises Euros 4 Million in series A fundraising

Pre-Clinical data supports potential of Cobra's proprietary ORT-VAC oral bacterial vaccine

Novagali appoints Dr Florence Barouki-Binlich vice-president development and medical affairs

Global Life Science Ventures and Atlas Venture co-lead investment into Fibrex Medical Inc.

Hana Biosciences Announces Positive Pharmacokinetic Study Results Of Ondansetron Lingual Spray

PharmaVentures announces launch of ddcr.com New web site to enable drug delivery deal making

Why Aren't Drugs Safer? - Is It Because We Need A Fundamental Understanding of the Receptor Response?

IDS Ltd acquire Suomen Bioanalyytiikka Oy (SBA)

Bayer Healthcare Diagnostics and Oxford Genome Sciences Partner in Proteomics-based Evaluation of New Biomarkers for Breast Cancer

IntegraGen opens the door to its new Expert Center for genetic testing and counseling

USC Marshall School of Business Announces Finalists for Asia-Pacific BioBusiness Leadership Award 2005

Syngene New 2-D Gel Scanner Guarantees Unbeatable Spot Detection

Oxford Biomedica Demonstrates That Its Lentivector Technology Is The System Of Choice For RNAi Applications

JOINS SOLEXA AS VP AND CHIEF TECHNICAL OFFICER

Intercell is listed on the Vienna Stock Exchange

Solexa Completes First Full Genome Sequence With Cluster-SBS Technology

Archemix CEO to Present at 25th Annual SG Cowen Health Care Conference

Nonlinear Dynamics’ TotalLab Software Suite now compatible with Mac

SENEXIS ENTERS INTO A COLLABORATION WITH BIOFOCUS TO DEVELOP NOVEL “SMALL MOLECULE” DRUGS FOR THE TREATMENT OF ALZHEIMER’S DISEASE

Study shows skin sterol identifies hidden CVD risks

Biacore acquires FLEXChip System and Technology from HTS BioSystems Inc

Member States fail to vote on biotech maize

Sage Group Expands Team – Dr. Josef Bossart Joins As New Executive Director

Agilent Technologies Introduces Whole Rat Genome Oligonucleotide Microarray

Agilent Technologies Introduces Secure Web Portal for Designing Custom Microarrays for Genomic Research

Update - Room for improved application of Orphan Medicines rules in Europe, says biotech industry - New White Paper sets out key recommendations

LYNX AND SOLEXA LTD COMBINE TO BECOME SOLEXA, INC.

BioAlliance Pharma Announces Results Demonstrating Styrylquinolines Targeting HIV Integrase Are Synergistic With Other Antiretroviral Agents

DowpharmaSM Announces Agreement with Pfizer Inc using Pfēnex Expression TechnologyTM and Dow Solvent Extraction Technology

Oxford BioMedica Announces Board Appointment

Cytocell Technologies Completes Management Buy-Out. Management Team Takes Control of Biotech Diagnostic Screening Company

Room for improved application of Orphan Medicines rules in Europe, says biotech industry - New White Paper sets out key recommendations

GENOME express signs agreement with bioMérieux

Sankyo and Daiichi plans show Japanese consolidation goes on

Updated - Biopharmaceutical Contract Manufacturing: HighTech Business Decisions Report Indicates New Capacity and Improved Processes Keep the Industry on the Cutting Edge

Updated - UNIBIOSCREEN’S Board Of Directors Appoints Pierre Hochuli As Chairman Of The Executive Committee

NIH awards two-year grant to explore the causal relationship between epoetin dose and survival of hemodialysis patients receiving this therapy

UNIBIOSCREEN’S Board Of Directors Appoints Pierre Hochuli As Chairman Of The Executive Committee

Biopharmaceutical Contract Manufacturing: HighTech Business Decisions Report Indicates New Capacity and Improved Processes Keep the Industry on the Cutting Edge

Grant Instruments acquires major share in Biosan

SUPER-REPELLENT BIODEFENCE COATING FINDS HEALTHY APPLICATIONS

Emerging oncology treatments: A focus on targeted therapeutics, supergeneric reformulations and supportive care

Cresset Biomolecular Discovery Ltd Forms a Lead-Finding Collaboration with Pharmagene

Medical Device Innovations closes £2.9m funding round

Oxford Biomedica Announces Encouraging Results From Three Phase Ii Trials Of Trovax In Patients With Colorectal Cancer

Cobra signs agreement with Hawaii Biotech Inc to manufacture two novel protein vaccines against Dengue fever and West Nile disease for US clinical trials

Biopharmaceutical Contract Manufacturing: HighTech Business Decisions Report Indicates New Capacity and Improved Processes Keep the Industry on the Cutting Edge

UNIBIOSCREEN’S Board Of Directors Appoints Pierre Hochuli As Chairman Of The Executive Committee

MYORES, a EUR12 million European network of excellence focusing on muscle pathology research starts work

BioNewsCast Press Release Service 2005 Archive

BioNewsCast Press Release Service 2004 Archive

BioNewsCast Press Release Service 2003 Archive

BioNewsCast Press Release Service 2002 Archive

 
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.